Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets closed
FTSE 100
8,433.76
+52.41
(+0.63%)
FTSE 250
20,645.38
+114.08
(+0.56%)
AIM
789.87
+6.17
(+0.79%)
GBP/EUR
1.1622
+0.0011
(+0.09%)
GBP/USD
1.2525
+0.0001
(+0.01%)
Bitcoin GBP
48,672.04
+43.63
(+0.09%)
MONEY
Best savings accounts that offer above inflation rates
How to earn the most interest on your savings
AN2 Therapeutics, Inc. (ANTX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.4200
-0.0500
(-2.02%)
At close: 04:00PM EDT
2.4700
+0.05
(+2.07%)
After hours:
05:37PM EDT
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
54,871
54,871
29,511
16,906
6,019
Selling general and administrative
14,764
14,764
12,751
4,668
1,265
Total operating expenses
69,635
69,635
42,262
21,574
7,284
Operating income or loss
-69,635
-69,635
-42,262
-21,574
-7,284
Total other income/expenses net
4,903
4,903
1,306
-38
-6,322
Income before tax
-64,732
-64,732
-40,956
-21,543
-13,603
Income from continuing operations
-64,732
-64,732
-40,956
-21,543
-13,603
Net income
-64,732
-64,732
-40,956
-21,543
-13,603
Net income available to common shareholders
-64,732
-64,732
-42,776
-28,058
-13,603
Basic EPS
-2.80
-2.74
-2.79
-1.55
-0.97
Diluted EPS
-2.80
-2.74
-2.79
-1.55
-0.97
Basic average shares
20,999
23,600
15,340
18,140
14,048
Diluted average shares
20,999
23,600
15,340
18,140
14,048
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.